1-6 of 6
Darren Newton
Close
Sort by
Journal Articles

Ibrutinib and Rituximab Versus Fludarabine, Cyclophosphamide, and Rituximab for Patients in NCRI FLAIR Study with Previously Untreated CLL: Assessment of Mutational Landscape of Patients at Baseline and Prognostic Impact

Surita Dalal, Anita Sarma, Jane Shingles, Paul Glover, Helen Warren, Thomas Grand, Nichola Webster, Andy Rawstron, Darren Newton, Sue Bell, David Allan Cairns, Sean Girvan, Natasha Greatorex, Anna Hockaday, Sharon Jackson, David Phillips, David Stones, David Allsup, Adrian John Clifton Bloor, Abraham Mullasseril Varghese, Talha Munir, Peter Hillmen
Journal: Blood
Blood (2023) 142 (Supplement 1): 4637.
https://doi.org/10.1182/blood-2023-180527
Published: 2023
Journal Articles

Molecular Analysis at Relapse of Patients Treated on the Ibrutinib and Rituximab Arm of the National Multi-Centre Phase III FLAIR Study in Previously Untreated CLL Patients

Anita Sarma, Charlotte Evans, Surita Dalal, Nichola Webster, Andy Rawstron, Jane Shingles, Darren Newton, David Allan Cairns, Paul Glover, Thomas Grand, Helen Warren, Sue Bell, Sean Girvan, Natasha Greatorex, Anna Hockaday, Sharon Jackson, David Phillips, David Stones, David Allsup, Adrian John Clifton Bloor, Abraham Mullasseril Varghese, Talha Munir, Peter Hillmen
Journal: Blood
Blood (2023) 142 (Supplement 1): 4636.
https://doi.org/10.1182/blood-2023-188597
Published: 2023
Journal Articles

Paroxysmal Nocturnal Haemoglobinuria (PNH) Arising from Non-Canonical Mutations

Alexandra Pike, Stephen John Richards, Claire E McKinley, Louise M Arnold, Abraham Mullasseril Varghese, Talha Munir, Petra Muus, Peter Hillmen, Morag Griffin, Richard J Kelly, Darren Newton
Journal: Blood
Blood (2023) 142 (Supplement 1): 4097.
https://doi.org/10.1182/blood-2023-188755
Published: 2023
Journal Articles

Sars-Cov-2 Antibody and T-Cell Responses in Patients with Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia after Four COVID-19 Vaccinations

Alexandra Pike, Natalie Fox, Claire E McKinley, Louise M Arnold, Mark Harland, Deborah Clarke, Briony Forrest, Nicola Houghton, Nora Youngs, Emily Charlton, Tapiwa Zhakata, Catherine Barnfield, Ruth Harvey, Mary Wu, Caitlin Kavanagh, Stephen John Richards, Daniel Payne, Abraham Mullasseril Varghese, Sateesh Nagumantry, Talha Munir, Petra Muus, Morag Griffin, Darren Newton, Peter Hillmen, Richard J Kelly
Journal: Blood
Blood (2023) 142 (Supplement 1): 2712.
https://doi.org/10.1182/blood-2023-190393
Published: 2023
Journal Articles

Molecular Mechanisms of Ibrutinib Resistance: Defining a Logical Approach to Improving Targeted Therapy in CLL

Sara MK Farag, MBBCh, MSc in MDcal sciences, Darren Newton, PhD, Gina Doody, Associate Professor, Molecular Immunology, Lotfy Abdelnaby Mahmoud, Professor of Haematology, Manal Ibrahim Fouda, Professor of Haematology, Doaa Mahmoud El Ghannam, Professor of Clinical Pathology, Peter Hillmen
Journal: Blood
Blood (2016) 128 (22): 2046.
https://doi.org/10.1182/blood.V128.22.2046.2046
Published: 2016
Journal Articles

Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL

Anna Vardi, Antonis Dagklis, Lydia Scarfò, Diane Jelinek, Darren Newton, Fiona Bennett, Julia Almeida, Arancha Rodriguez-Caballero, Sallie Allgood, Mark Lanasa, Agostino Cortelezzi, Ester Orlandi, Silvio Veronese, Marco Montillo, Andy Rawstron, Tait Shanafelt, Alberto Orfao, Kostas Stamatopoulos, Paolo Ghia
Journal: Blood
Blood (2013) 121 (22): 4521–4528.
https://doi.org/10.1182/blood-2012-12-471698
Published: 2013
Includes: Supplemental data